Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dichloroacetate for Brain Function in Type 1 Diabetes Hypoglycemia
NCT05317455Phase 1Recruiting
- Sponsor
- Yale University
- Start
- May 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Hypoglycemia unawareness (HU) comparing Placebo with Dichloroacetate (2 arms). Primary endpoint: Cognitive Function at 1 day. Started May 2025; status: recruiting.
02
Drugs
dichloroacetate
03
Conditions
Hypoglycemia unawareness (HU)
Beyond the preview
Go deeper on NCT05317455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05317455.